{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:54:13Z","timestamp":1777942453801,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Vasc Endovascular Surg"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>The treatment of femoropopliteal artery disease remains controversial, without clear guidelines specifying the indications for endovascular therapy (EVT). Accordingly, we retrospectively examined our experience of using EVT to treat femoropopliteal artery disease. A total of 91 limbs in 82 patients underwent EVT for the treatment of femoropopliteal artery disease. Percutaneous transluminal angioplasty alone was performed in 20 limbs, and additional stenting was performed in 71 limbs. The 1-year primary patency, primary-assisted patency, limb salvage, and survival rates were 76%, 88%, 96%, and 92%, respectively. Multivariate Cox analysis of primary patency showed that critical limb ischemia (CLI; hazard ratio [HR], 2.53; 95% confidence interval [CI], 1.08-5.33; P &lt; .01) and TASC II C\/D disease (HR, 2.70; 95% CI, 1.14-6.39; P &lt; .05) were independent predictors of decreased primary patency. In conclusion, patients with CLI or extensive lesions have reduced patency after EVT for femoropopliteal artery disease.<\/jats:p>","DOI":"10.1177\/1538574415614406","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T21:09:50Z","timestamp":1447708190000},"page":"236-241","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency"],"prefix":"10.1177","volume":"49","author":[{"given":"Toshiya","family":"Nishibe","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Seike","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Nishibe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Eniwa Midorino Clinic, Eniwa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Dardik","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"bibr1-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"bibr2-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.06.025"},{"key":"bibr3-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2010.11.001"},{"key":"bibr4-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67704-5"},{"key":"bibr5-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-008-3812-9"},{"key":"bibr6-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-5214(97)70045-4"},{"key":"bibr7-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1177\/0003319712437031"},{"key":"bibr8-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2005.03.007"},{"key":"bibr9-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.04.054"},{"key":"bibr10-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2004.11.031"},{"key":"bibr11-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.03.286"},{"key":"bibr12-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1177\/000313480507100605"},{"key":"bibr13-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.06.025"},{"key":"bibr14-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2009.09.044"},{"key":"bibr15-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.11.016"},{"key":"bibr16-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.09.069"},{"key":"bibr17-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2009.04.019"},{"key":"bibr18-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.12.050"},{"key":"bibr19-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2011.10.108"},{"key":"bibr20-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2322031345"},{"key":"bibr21-1538574415614406","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051303"}],"container-title":["Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1538574415614406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1538574415614406","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1538574415614406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:57:05Z","timestamp":1777705025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1538574415614406"}},"subtitle":["The Implication of Critical Limb Ischemia and TASC II C\/D Disease"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1177\/1538574415614406"],"URL":"https:\/\/doi.org\/10.1177\/1538574415614406","relation":{},"ISSN":["1538-5744","1938-9116"],"issn-type":[{"value":"1538-5744","type":"print"},{"value":"1938-9116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}